FDA NDC Directory · JSON-LD · Markdown

Primidone

NDC 42291-511 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA040866
Dosage form / routeTABLET · ORAL
Active ingredientsPRIMIDONE (250 mg/1)
Marketing started20220322
Marketing ended20261130
Package count1

External sources

Source: openFDA. Public-domain (CC0).